BN Business News
Add your company to Business Communicator →

Zdrowie i gospodarka · 10/06/2016

FDA Releases Guidance on Compounding with Bulk Drug Substances

The FDA has announced the availability of a guidance document outlining its interim policy on compounding with bulk drug substances, which will allow licensed pharmacists and physicians to use these substances to create human drug products while the agency develops a list of approved substances.

Source: Federal Register — Food and Drug AdministrationOpen original release →